BOAS
B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1751
EverQuote
EVER
$860M
|
NS
Nat Schindler
| $23.54 | $48 |
104%
upside
| Underperform | 5 years ago |
|
1752
IAC Inc
IAC
$2.98B
|
NS
Nat Schindler
| $37.19 | $148 |
298%
upside
| Buy | 5 years ago |
|
1753
Zions Bancorporation
ZION
$8.34B
|
EN
Erika Najarian
| $56.52 | $39 |
31%
downside
| Neutral | 5 years ago |
|
1754
Huntington Bancshares
HBAN
$25.7B
|
EN
Erika Najarian
| $17.63 | $11 |
38%
downside
| Buy | 5 years ago |
|
1755
Comerica
CMA
$8.85B
| $68.86 | $45 |
35%
downside
| Underperform | 5 years ago |
|
|
1756
Citigroup
C
$176B
|
EN
Erika Najarian
| $95.40 | $74 |
22%
downside
| Buy | 5 years ago |
|
1757
Virtus Investment Partners
VRTS
$1.31B
|
MC
Michael Carrier
| $193.98 | $154 |
21%
downside
| Buy | 5 years ago |
|
1758
Artisan Partners
APAM
$3.26B
|
AP
Artisan Partners
| $46.30 | $39 |
16%
downside
| Buy | 5 years ago |
|
1759
Affiliated Managers Group
AMG
$6.54B
|
MC
Michael Carrier
| $230.28 | $71 |
69%
downside
| Underperform | 5 years ago |
|
1760
KKR & Co
KKR
$121B
|
MC
Michael Carrier
| $135.53 | $40 |
70%
downside
| Buy | 5 years ago |
|
1761
Carlyle Group
CG
$23.1B
|
MC
Michael Carrier
| $63.75 | $27 |
58%
downside
| Underperform | 5 years ago |
|
1762
Blackstone
BX
$133B
|
MC
Michael Carrier
| $169.99 | $58 |
66%
downside
| Neutral | 5 years ago |
|
1763
Ares Management
ARES
$38.9B
|
MC
Michael Carrier
| $177.31 | $44 |
75%
downside
| Buy | 5 years ago |
|
1764
Apollo Global Management
APO
$75.3B
|
MC
Michael Carrier
| $131.55 | $53 |
60%
downside
| Neutral | 5 years ago |
|
1765
Nasdaq
NDAQ
$53.6B
|
MC
Michael Carrier
| $93.48 | $46.67 |
50%
downside
| Buy | 5 years ago |
|
1766
Caterpillar
CAT
$198B
|
RG
Ross Gilardi
| $423.08 | $135 |
68%
downside
| Neutral | 5 years ago |
|
1767
CoStar Group
CSGP
$37.9B
|
DC
David Chu
| $89.46 | $85 |
5%
downside
| Buy | 5 years ago |
|
1768
Ecolab
ECL
$77.6B
|
GB
Gary Bisbee
| $273.56 | $212 |
23%
downside
| Neutral | 5 years ago |
|
1769
Charles River Laboratories
CRL
$8.07B
|
JA
Juan Avendano
| $163.99 | $192 |
17%
upside
| Buy | 5 years ago |
|
1770
Bain Capital Specialty
BCSF
$1.02B
|
DH
Derek Hewett
| $15.67 | $12 |
23%
downside
| Neutral | 5 years ago |
|
1771
Puma Biotechnology
PBYI
$253M
|
GM
Geoff Meacham
| $5.03 | $9 |
79%
upside
| Underperform | 5 years ago |
|
1772
Regenxbio
RGNX
$490M
|
GM
Geoff Meacham
| $9.71 | $60 |
518%
upside
| Buy | 5 years ago |
|
1773
Option Care Health
OPCH
$4.72B
|
KF
Kevin Fischbeck
| $29.09 | $18 |
38%
downside
| Buy | 5 years ago |
|
1774
Rayonier Advanced Materials
RYAM
$397M
|
JB
John Babcock
| $5.93 | $3.60 |
39%
downside
| Buy | 5 years ago |
|
1775
DexCom
DXCM
$31.6B
|
TS
Travis Steed
| $80.51 | $125 |
55%
upside
| Buy | 5 years ago |
|